Details: Written by: Administrator; Published: 18 September 2014

Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration (AMD).

Read more: News on AMD drug (2)

Details: Written by: Administrator; Published: 11 September 2014

The research team of Jean Bennett reported a clinical phase 3 study on the efficacy of the RPE65 gene therapy vector.

Continue reading: News on the RPE65 phase-3 Gene Therapy Trials

Details: Written by: Administrator; Published: 09 September 2014

The new RPQure Neuromedical Genetics website is up and running to inform about progress in retinal gene therapy, especially on retinitis pigmentosa and Leber congenital amaurosis due to mutations in the CRB1 gene.

Continue reading: New RPQure website

Page 4 of 4